Gadolinium Lawsuit

If you or a loved one had a major medical imaging (MRI or MRA) and you suffered a stroke, you may be entitled to file a gadolinium lawsuit. GAD is an element that is naturally present in the human body; however, it becomes toxic when it is combined with calcium. Medical imaging tests use these two elements to create detailed images of the body’s organs or blood vessels. GAD affects how these images are interpreted and can result in a faulty diagnosis.

Medical imaging uses various chemical compounds, including antirailion agents, contrast media, radioisotopes, and superconductors to create detailed images of the body or organs.

Unfortunately, these compounds can react with calcium, which is found in the brain, heart, and bones. The combination of these materials can result in a fatal overdose of calcium that may require a gadolinium lawsuit to be filed against the manufacturers of medical imaging products.

The U.S Food and Drug Administration (FDA) is responsible for regulating the production of medical imaging drugs and other medications.

Due to these new studies that have come to light regarding these dangerous side effects, these companies have been ordered to produce large amounts of drugs free of gadolinium. Although there are many lawsuits against these manufacturers, it is believed that these large-scale companies will appeal these cases to the U.S. Supreme Court.

Many of the lawsuits were filed by patients who suffered from severe side effects from the use of these contrast media.

These side effects include nausea, vomiting, and heart palpitations. Due to these symptoms, many patients were unable to continue their treatments. Some doctors even felt that the mri contrast dyes could cause strokes in patients that underwent them.

Unfortunately, the FDA did not hear testimony from a number of physicians or patients that have died as a result of these mri products, despite the fact that they suffered from acute side effects from these products.

After reviewing these issues with the FDA, we discovered that the FDA failed to take the time to thoroughly review the data that was presented in these lawsuits. Furthermore, there was never an opportunity to evaluate the safety of these contrast media and to determine whether or not the more toxins actually caused these deaths or injuries. This is why we believe that the U.S. District Court for the District of Minnesota incorrectly concluded that the plaintiffs had a valid claim for a gadolinium retention.

The FDA must take more time to fully evaluate these products before it allows the production of them.

Currently, it has been ruled that there are no established links between the ingestion of acyclovir and cancer. We urge the FDA to quickly review the current medical data and determine whether or not these claims are true. If these claims are proven to be false, then the FDA must permanently ban all forms of gadolinium retention using all unnecessary amounts of the metal. Please click here for more information on this important topic.